AU609794B2 - A test set and a process for the determination of antibiotics in milk and a novel streptococcus thermophilus strain to be used therein - Google Patents
A test set and a process for the determination of antibiotics in milk and a novel streptococcus thermophilus strain to be used therein Download PDFInfo
- Publication number
- AU609794B2 AU609794B2 AU14158/88A AU1415888A AU609794B2 AU 609794 B2 AU609794 B2 AU 609794B2 AU 14158/88 A AU14158/88 A AU 14158/88A AU 1415888 A AU1415888 A AU 1415888A AU 609794 B2 AU609794 B2 AU 609794B2
- Authority
- AU
- Australia
- Prior art keywords
- test set
- milk
- antibiotics
- indicator
- streptococcus thermophilus
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
- 238000012360 testing method Methods 0.000 title claims abstract description 45
- 238000000034 method Methods 0.000 title claims abstract description 36
- 235000013336 milk Nutrition 0.000 title claims abstract description 26
- 239000008267 milk Substances 0.000 title claims abstract description 26
- 210000004080 milk Anatomy 0.000 title claims abstract description 26
- 239000003242 anti bacterial agent Substances 0.000 title claims abstract description 19
- 229940088710 antibiotic agent Drugs 0.000 title claims abstract description 19
- 241000194020 Streptococcus thermophilus Species 0.000 title claims abstract description 14
- 239000003223 protective agent Substances 0.000 claims abstract description 13
- 239000012141 concentrate Substances 0.000 claims abstract description 9
- 238000010790 dilution Methods 0.000 claims abstract description 6
- 239000012895 dilution Substances 0.000 claims abstract description 6
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 6
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 claims description 4
- XJRPTMORGOIMMI-UHFFFAOYSA-N ethyl 2-amino-4-(trifluoromethyl)-1,3-thiazole-5-carboxylate Chemical group CCOC(=O)C=1SC(N)=NC=1C(F)(F)F XJRPTMORGOIMMI-UHFFFAOYSA-N 0.000 claims description 4
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 claims description 3
- 239000008101 lactose Substances 0.000 claims description 3
- 235000015097 nutrients Nutrition 0.000 claims description 3
- 239000007864 aqueous solution Substances 0.000 claims description 2
- 235000010323 ascorbic acid Nutrition 0.000 claims description 2
- 229960005070 ascorbic acid Drugs 0.000 claims description 2
- 239000011668 ascorbic acid Substances 0.000 claims description 2
- PXEDJBXQKAGXNJ-QTNFYWBSSA-L disodium L-glutamate Chemical compound [Na+].[Na+].[O-]C(=O)[C@@H](N)CCC([O-])=O PXEDJBXQKAGXNJ-QTNFYWBSSA-L 0.000 claims description 2
- 235000013923 monosodium glutamate Nutrition 0.000 claims description 2
- 229940073490 sodium glutamate Drugs 0.000 claims description 2
- 235000009917 Crataegus X brevipes Nutrition 0.000 claims 1
- 235000013204 Crataegus X haemacarpa Nutrition 0.000 claims 1
- 235000009685 Crataegus X maligna Nutrition 0.000 claims 1
- 235000009444 Crataegus X rubrocarnea Nutrition 0.000 claims 1
- 235000009486 Crataegus bullatus Nutrition 0.000 claims 1
- 235000017181 Crataegus chrysocarpa Nutrition 0.000 claims 1
- 235000009682 Crataegus limnophila Nutrition 0.000 claims 1
- 235000004423 Crataegus monogyna Nutrition 0.000 claims 1
- 240000000171 Crataegus monogyna Species 0.000 claims 1
- 235000002313 Crataegus paludosa Nutrition 0.000 claims 1
- 235000009840 Crataegus x incaedua Nutrition 0.000 claims 1
- 210000002837 heart atrium Anatomy 0.000 claims 1
- 230000003115 biocidal effect Effects 0.000 description 10
- 241000894006 Bacteria Species 0.000 description 9
- 229930182555 Penicillin Natural products 0.000 description 9
- JGSARLDLIJGVTE-MBNYWOFBSA-N Penicillin G Chemical compound N([C@H]1[C@H]2SC([C@@H](N2C1=O)C(O)=O)(C)C)C(=O)CC1=CC=CC=C1 JGSARLDLIJGVTE-MBNYWOFBSA-N 0.000 description 9
- 230000012010 growth Effects 0.000 description 9
- 229940049954 penicillin Drugs 0.000 description 9
- 239000003708 ampul Substances 0.000 description 6
- 244000005700 microbiome Species 0.000 description 5
- 230000035945 sensitivity Effects 0.000 description 5
- 229920001817 Agar Polymers 0.000 description 4
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 4
- 239000008272 agar Substances 0.000 description 4
- 235000013365 dairy product Nutrition 0.000 description 4
- 238000001514 detection method Methods 0.000 description 4
- 239000000243 solution Substances 0.000 description 4
- 241000193385 Geobacillus stearothermophilus Species 0.000 description 3
- 239000004100 Oxytetracycline Substances 0.000 description 3
- 239000001963 growth medium Substances 0.000 description 3
- 229960000625 oxytetracycline Drugs 0.000 description 3
- IWVCMVBTMGNXQD-PXOLEDIWSA-N oxytetracycline Chemical compound C1=CC=C2[C@](O)(C)[C@H]3[C@H](O)[C@H]4[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]4(O)C(O)=C3C(=O)C2=C1O IWVCMVBTMGNXQD-PXOLEDIWSA-N 0.000 description 3
- 235000019366 oxytetracycline Nutrition 0.000 description 3
- 238000002360 preparation method Methods 0.000 description 3
- IWVCMVBTMGNXQD-UHFFFAOYSA-N terramycin dehydrate Natural products C1=CC=C2C(O)(C)C3C(O)C4C(N(C)C)C(O)=C(C(N)=O)C(=O)C4(O)C(O)=C3C(=O)C2=C1O IWVCMVBTMGNXQD-UHFFFAOYSA-N 0.000 description 3
- ULGZDMOVFRHVEP-RWJQBGPGSA-N Erythromycin Chemical compound O([C@@H]1[C@@H](C)C(=O)O[C@@H]([C@@]([C@H](O)[C@@H](C)C(=O)[C@H](C)C[C@@](C)(O)[C@H](O[C@H]2[C@@H]([C@H](C[C@@H](C)O2)N(C)C)O)[C@H]1C)(C)O)CC)[C@H]1C[C@@](C)(OC)[C@@H](O)[C@H](C)O1 ULGZDMOVFRHVEP-RWJQBGPGSA-N 0.000 description 2
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 2
- 239000005862 Whey Substances 0.000 description 2
- 108010046377 Whey Proteins Proteins 0.000 description 2
- 102000007544 Whey Proteins Human genes 0.000 description 2
- 239000002253 acid Substances 0.000 description 2
- 230000003698 anagen phase Effects 0.000 description 2
- 238000003556 assay Methods 0.000 description 2
- DAURDKVYTCCHPB-UHFFFAOYSA-N carbonic acid;sulfurous acid Chemical compound OC(O)=O.OS(O)=O DAURDKVYTCCHPB-UHFFFAOYSA-N 0.000 description 2
- 238000009792 diffusion process Methods 0.000 description 2
- 238000011156 evaluation Methods 0.000 description 2
- 235000013305 food Nutrition 0.000 description 2
- 238000011534 incubation Methods 0.000 description 2
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 2
- 239000012466 permeate Substances 0.000 description 2
- 239000007793 ph indicator Substances 0.000 description 2
- 239000000843 powder Substances 0.000 description 2
- 235000008476 powdered milk Nutrition 0.000 description 2
- 239000011780 sodium chloride Substances 0.000 description 2
- UCSJYZPVAKXKNQ-HZYVHMACSA-N streptomycin Chemical compound CN[C@H]1[C@H](O)[C@@H](O)[C@H](CO)O[C@H]1O[C@@H]1[C@](C=O)(O)[C@H](C)O[C@H]1O[C@@H]1[C@@H](NC(N)=N)[C@H](O)[C@@H](NC(N)=N)[C@H](O)[C@H]1O UCSJYZPVAKXKNQ-HZYVHMACSA-N 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- GUBGYTABKSRVRQ-XLOQQCSPSA-N Alpha-Lactose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-XLOQQCSPSA-N 0.000 description 1
- 241000283690 Bos taurus Species 0.000 description 1
- 241001478240 Coccus Species 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 229930193140 Neomycin Natural products 0.000 description 1
- 229930006000 Sucrose Natural products 0.000 description 1
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
- 239000004098 Tetracycline Substances 0.000 description 1
- 229960000723 ampicillin Drugs 0.000 description 1
- AVKUERGKIZMTKX-NJBDSQKTSA-N ampicillin Chemical compound C1([C@@H](N)C(=O)N[C@H]2[C@H]3SC([C@@H](N3C2=O)C(O)=O)(C)C)=CC=CC=C1 AVKUERGKIZMTKX-NJBDSQKTSA-N 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
- 230000031018 biological processes and functions Effects 0.000 description 1
- 229940041514 candida albicans extract Drugs 0.000 description 1
- 108010079058 casein hydrolysate Proteins 0.000 description 1
- 238000001311 chemical methods and process Methods 0.000 description 1
- 230000000973 chemotherapeutic effect Effects 0.000 description 1
- 229960005091 chloramphenicol Drugs 0.000 description 1
- WIIZWVCIJKGZOK-RKDXNWHRSA-N chloramphenicol Chemical compound ClC(Cl)C(=O)N[C@H](CO)[C@H](O)C1=CC=C([N+]([O-])=O)C=C1 WIIZWVCIJKGZOK-RKDXNWHRSA-N 0.000 description 1
- 239000003086 colorant Substances 0.000 description 1
- 235000013681 dietary sucrose Nutrition 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 229960003276 erythromycin Drugs 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 238000004108 freeze drying Methods 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 239000000383 hazardous chemical Substances 0.000 description 1
- 231100000206 health hazard Toxicity 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 235000014655 lactic acid Nutrition 0.000 description 1
- 239000004310 lactic acid Substances 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 239000002609 medium Substances 0.000 description 1
- 230000002906 microbiologic effect Effects 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 230000000877 morphologic effect Effects 0.000 description 1
- 229960004927 neomycin Drugs 0.000 description 1
- 235000020185 raw untreated milk Nutrition 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 238000012216 screening Methods 0.000 description 1
- 235000021262 sour milk Nutrition 0.000 description 1
- 238000010561 standard procedure Methods 0.000 description 1
- 230000001954 sterilising effect Effects 0.000 description 1
- 238000004659 sterilization and disinfection Methods 0.000 description 1
- 229960005322 streptomycin Drugs 0.000 description 1
- 229960004793 sucrose Drugs 0.000 description 1
- 229960002180 tetracycline Drugs 0.000 description 1
- 229930101283 tetracycline Natural products 0.000 description 1
- 235000019364 tetracycline Nutrition 0.000 description 1
- 150000003522 tetracyclines Chemical class 0.000 description 1
- 239000012137 tryptone Substances 0.000 description 1
- 239000003643 water by type Substances 0.000 description 1
- 239000012138 yeast extract Substances 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/02—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving viable microorganisms
- C12Q1/04—Determining presence or kind of microorganism; Use of selective media for testing antibiotics or bacteriocides; Compositions containing a chemical indicator therefor
- C12Q1/14—Streptococcus; Staphylococcus
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/02—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving viable microorganisms
- C12Q1/18—Testing for antimicrobial activity of a material
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/195—Assays involving biological materials from specific organisms or of a specific nature from bacteria
- G01N2333/315—Assays involving biological materials from specific organisms or of a specific nature from bacteria from Streptococcus (G), e.g. Enterococci
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Wood Science & Technology (AREA)
- Engineering & Computer Science (AREA)
- Zoology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Immunology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Analytical Chemistry (AREA)
- Microbiology (AREA)
- Molecular Biology (AREA)
- Physics & Mathematics (AREA)
- Toxicology (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- Biotechnology (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Dairy Products (AREA)
- Saccharide Compounds (AREA)
- Compounds Of Unknown Constitution (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Investigating Or Analysing Biological Materials (AREA)
Abstract
The invention relates to a test set suitable for the determination of antibiotics in milk and comprising a Streptococcus thermophilus T101 concentrate and a water-based protective agent in a dilution ratio of 4 to 5 x 10<-><2>. The invention is also concerned with a novel Streptococcus thermophilus T101 strain to be used in the test set and with a process of determining antibiotics in milk by means of said test set.
Description
COMMONWEALTH OF AUSTRALIA 6 K..
PATENTS ACT 1952-69 COMPLETE SPECIFICATION
(ORIGINAL)
Class Application Number: Lodged: Int. Class Cprnpleta Specif icatlon Lodged: Accepted: .0t# Published: Priority: Related Art, a C NRape of Applicant: Address of Applicant: VALIO MEIJERIEN KESKUSOSUUSLIIKE Actual Inventor: Address for Service: Kalevankatu 56, SF-00180 Helsinki, Finland ANNIKAL MAYRA-MAKINEN EDWD. WATERS SONS, 50 QUEEN STREET, MELBOURNE, AUSTRALIA, 3000.
Complete Specification for the invention entitled: A TEST SET AND A PROCESS FOR THE DETERMINATION OF ANTIBIOTICS IN MILK AND A NOVEL STREPTOCOCCUS THERMOPHILUS STRAIN TO BE USED THEREIN The following statement is a full description of this invention, including the best methtod of performing it known to :-u Seal of Company and Signatures of its Olficers as by prescribed by its Articles of Association, A s s o c l t, D. B. Mischlewski A test set and a process for the determination of antibiotics in milk and a novel Streptococcus thermophilus strain to be used therein The invention relates to a test set suitable Sfor the determination of antibiotics in milk. The invention is also concerned with a novel Streptococcus thermophilus strain to be used in the test set and a Scc process for the determination of antibiotics in milk ao 6 by means of said test set.
0ce In many situations it is of vital importance to be able to detect the presence of small amounts of antibiotics. This is the case in food industries, for instance, where the increased use of antibiotics and chemotherapeutic substances in the treatment of animals has created a need for a simple, reliable and sensitive process of determination. Since antibiotics ;are used also in the treatment of dairy cows and since antibiotic residues in milk may both cause health hazards and be disadvantageous for food technological reasons, it is especially important to develop processes suitable for an accurate and rapid screening of o milk.
Antibiotic residues in milk are generally detected by microbiological processes which utilize the fact that bacteria are able to produce acid, reduce colours and produce growth on an agar medium. These processes are based on the bactericidal, inhibitory and morphological effect of antibiotics on certain microorganisms.
I The Thermocult disk technique is an agar diffusion technique which is widely used in Finland and S accepted as an official antibiotic determination procedure. In this technique the test organism is B. stearothermophilus var. calidolactis. It has been
V
2 developed on the basis of an IDF standard process (IDF 1970. Detection of Penicillin in Milk by a Disk Assay Technique. International Standard FIL-IDF 57. Brussels).
A process of corresponding sensitivity is disclosed by van OS et al., Diffusion Test for the Determination of Antibiotic Residues in Milk. Neth. Milk and Dairy J. 29 (1975) 16. The Delvotest process, too, uses B. stearothermophilus var. calidolactis as the i ctest organism. A sample (0.1 ml) is pipetted on agar S, contained in an ampoule, and a tablet containing nutrients and a pH indicator is added to the ampoule.
The process is based on the acid producing capability Ecc 'of the test organism. The ampoules are incubated at S' 64 0 C for 2.5 hours. The evaluation is based on the colour change of the agar layer.
Standard techniques further include the Intertest (BCP-Test). The test microbe used in the process S' is Str. thermophilus. A test tablet containing a lyoc*c philized culture of the test microbe, nutrients, and a C t t V pH indicator (bromocresol purple) is added to a milk sample. The incubation time is 4 hours at 45 0 C. If the sample does not contain any antibiotic, the colour of the solution turns from blue to green and further to yellow. The amount of the antibiotic can be determined to some extent on the basis of the colour by comparing to a colour map (THOROGOOD et al., An Evaluation on the Charm Test A Rapid Method for the Detection of Penicillin in milk. J. Dairy Research 50 (1983) 185).
A drawback of these processes is their insufficient sensitivity in view of the needs of milk technology.
The determination of antibiotic residues in milk by means of chemical or physico-chemical processes is considerably less usual than the use of micro- 3 biological processes. Colorimetric and chrLnatographic processes require skilled labour and often a complicated and expensive analyzing equipment. The processes are seldom suitable for routine analyses.
The Charm test (CHARM, A 15-minute Assay for Penicillin and other Antibiotics. Cultured Dairy Products J. 14 (1979) 24) is based on the detection of radioactivity. A lyophilized culture of B. stearothermophilus culture and lyophilized 14 C-labelled penicillin are added to a sample. The amount of 14
C
CO
contained in the bacterium cells is detected by a "0a Geiger counter; the lower the penicillin concentration cnco of the sample, the higher is the reading of the Geiger counter. The detection time is only 15 minutes and the sensitivity of the process is 0.005 I.U. of penicillin per ml. This process, either, is not suitable for routine use; it is expensive and complicated and requires 00 skilled persons and expensive equipment to be carried out.
a Thus there is still a practical need for a sensitive process which is as broad-spectrum as possible. The process should also be simple and it should be possible to carry out the process by an equipment ready for use, whereby the test does not require skilled persons, but can be carried out e.g. on a farm.
These advantages are obtained by means of a test set according to the invention, which is characterized in that it comprises a Streptococcus thermophilus TI01 concentrate and a water-based protective agent in a dilution ratio of 4 to 5 x 10-2. The determination is carried out according to the invention by adding a sample to a test set comprising a Streptococcus thermophilus T01 concentrate and a water-based protective agent in a dilution ratio of 4 to 5 x 10 2 r
S
4 and possibly an indicator, and if the test set does not comprise an indicator, an indicator is added, too; incubating the test set and the sample at 38 to 42 0
C
for about 4 hours; and evaluating the colour.
The invention is based on the novel Streptococcus thermophilus T101 strain, which has been isolated at the Lammi creamery of Valio. The strain has been deposited at the Deutsche Sammlung von Mikroor- C ganismen under the deposit number DSM 4022 on March 3, 1987, and it possesses the following properties: C gram positive, S- forms long coccus chains 0 'c growing temperature: growth at 50 0
C
no growth at 10 0
C
salt resistance growth at a NaCl concentration of 2% c no growth at a NaCl concentration of titrated acidity 25 to 29 OSH after 7-hour cc incubation at 42 0 C (sterilized 10% milk powder milk) lactic acid 0.8% (incubated 2 days at 42 0 C, from milk powder milk) S, fermentates lactose, saccharose and glucose.
Judging from the values given in the prior art, the novel microorganism strain is clearly more sensitive than known Streptococcus thermophilus strains, especially to penicillin and oxytetracycline.
The test set is prepared in the following way: The microorganism strain is grown in a fermentor at a pH of 6.2 to 6.5 and at 38 to 42 0 C in a culture medium based on whey permeate. The growth is observed and the growth is arrested at the end of the logarithmic growth phase, whereafter the culture broth is concentrated by filtrating to a 20-fold concentration. The I A| r I concentrate is measured in a dilution ratio of about 4 to 5 x 10-2, preferably about 5 x 10-2, into a protective agent. The protective agent may consist of water-based protective agents used in the preparation of lyophilized microbe preparations. Preferably the protective agent is an aqueous solution comprising 1.1% of sodium glutamate, 1.1% of ascorbic acid, and optionally 7% of lactose, and the pH of which is The indicator can be added to the protective agent, or c it can be added to the test set in connection with the determination. The indicator is e.g. an acid-base in- O dicator, such as bromocresol purple. The concentrate is measured into a vessel which may be a conventional o ampoule, a sealable test tube, a sample bottle, or the rco like. The vessel is cooled in a carbonic acid-sulphite alcohol bath, whereafter it is lyophilized and stored under vacuum. The finished test set contains about 1 to 2 x 106 bacteria per ml.
The antibiotic determination is carried out by adding a liquid sample and possibly an indicator to the test set. The test set and the sample are incubated and the colour changes are observed. If the C cc sample contains antibiotics, the microorganisms in the test set are not able to grow and the colour does not change. On the other hand, if the sample does not contain antibiotics, the microorganisms grow and induce a colour change while growing.
The sensitivity of the process according to the invention was compared with the corresponding commercial THERMOCULT (Orion Diagnostica) and DELVOTEST P i (Gist-Brocades) techniques and the CHARM II technique.
The sample consisted of milk preheated at 95 0 C for minutes and the determinations were carried out according to the instructions given by the manufacturers. The results are presented in the following i4
I
L :1 6 table, from which further appears the data given by the manufacturer Intervet concerning the INTERTEST.
The results show that the process according to the invention is more sensitive than the other processes and detects clearly the presence of all types of antibiotics/combinations.
c
CIE
I
I
non ftF t
TABLE
Experimentally determined antibiotic sensitivities (pg/ml) of the tested determination processes ANTIBIOTIC PROCESS ACCORDING TO THE THERMOCULT DELVOTEST P INTERTEST b) CHARM INVENTION TEST II A B own deter- a) own deter- a) mination mination PENICILLIN 0.001- 0.001- 0.006-0.0075 0.005- 0.0025 0.0025 0.005 0.003 0.002 I.U. 0.002 I.U. 0.0075 STREPTOMYCIN 1.25 0.25-0.4 5.0 2.5-5.0 5.0 2.5-5.0 5.0 0.1 TETRACYCLINE 0.05-0.1 0.05 0.2 c) 0.1 0.2 0.1 0.5 0.2 OXYTETRACYCLINE 0.1 0.05 0.2 c) 0.1 0.2 0.1 0.2 AMPICILLIN 0.01 0.003 0.01 c) 0.005 0.01 c) 0.005 0.005 ERYTHROMYCIN 0.01-0.05 0.01 0.1 c) 0.5-0.75 0.1 c) 0.75-1.0 0.1 0.01 CHLORAMPHENICOL 0.1-0.5 0.1 1.0 c) 7.5 1.0 c) 7.5-10.0 1.0 0.05 NEOMYCIN 0.5 0.1-0.2 0.5 1.0 1.0 0.5 20.0 STREPTOMAX 0.004 I.U. PEN 0.01 I.U. PEN (penicillin +0.001 pg/ml +0.008 pg/ml +streptom.) STREPTOM. STREPTOM.
MASTALONE 0.1 0.05 0.2 c) (oxytetracycline+the others) A indicator added in connection with the test (duration of the test 4 hours) B indicator added before freeze drying (duration of the test 5 hours) a) Sandstr6m Siveld, 1984, Karjantuote 4 b) concentrations given by the manufacturers c) could not be determined Fz^^ f, j 8 Example 1 Preparation of the test set Bacteria of the Streptococcus thermophilus T101 strain are inoculated in a culture medium having the following composition: of whey permeate powder of casein hydrolysate of tryptone 1% of yeast extract The culture medium has been sterilized at 120 0 C for c to 20 minutes, and its pH is 6.4 after the sterilization.
,cc The test strain is grown in a fermentor at a pH of about 6.2 and at about 42 0 C, and the growth is Smonitored by observing the turbidity of the culture broth. At the end of the logarithmic growth phase the growth is arrested and the culture broth is concentrated by filtrating using a Millipore Pellicon filtration unit (0.45 )um) to a 20-fold concentration, whereby the bacterium concentration of the concentrate is about 2 x 109 bacteria per ml. The concentrate is washed with a small amount of protective agent, and v, O about 5 ml is added to 100 ml of protective agent, whereto is possibly also added 1 ml of bromocresol purple colour (a 0.8% solution). The bacterium concentration of the solution so obtained is about 1 x 108 bacteria per ml. 1 ml of the solution is added to a conventional 10 ml ampoule which withstands drying and can be closed by vacuum. The ampoule is cooled rapidly to 60 s) in a -60 0 C carbonic acid-sulphite alcohol bath, whereafter it is freeze dried and vacuum closed for storage. The ampoule thus prepared contains 1 to 2 x 106 bacteria per ml.
2I E p 1_ Prepraton o th tes se 9 Example 2 Determination of antibiotics in a milk sample Raw milk is heated at 95 0 C for 5 minutes. 2 ml of milk and possibly 20 ,ul of a colour indicator are added to a test set prepared according to Example 1.
The test set is incubated for 4 hours at about 42 0
C
and the colour is evaluated. Milk prepared from sour milk powder and heated at 95 0 C for 5 minutes is used as a control. If the milk contains antibiotics, the colour turns blue. Yellow indicates a negative result.
r C C C C C t C I i c~c
Claims (6)
1. A test set suitable for the determination of antibiotics in milk, characterized in that it comprises a Streptococcus thermophilus T101 concentrate in a water-based protective agent in a dilution ratio of 4 to 5 x 10
2. A test set according to claim 1, characterized in that the protective agent comprises an aqueous solution comprising 1.1% of sodium glutamate, 1.1% of ascorbic acid, and optionally 7% of lactose, and the ph of which is
3. A test set according to claim 1, characterized in that it further comprises an indicator.
4. A test set according to claim 3, characterized in that the indicator is bromocresol purple.
5. Substantially pure culture of Streptococcus thermophilus tl01, dsm 4022 grown on a nutrient medium.
6. A process of determinating antibiotics in milk, characterized by the steps of adding a sample to a test set comprising a Streptococcus thermophilus Ti01 concentrate and a water-based protective agent in a dilution ratio of 4 to x 10- 2 and possibly an indicator, and if the test set does not contain an indicator, an indicator is also added; incubating the test set and the sample at 38 to 42 0 c for about 4 hours; and evaluating the colour. DATED this 28th day of November, 1990. VALIO MEIJERIEN KESKUSOSUUSLIIKE a a 0 Ca. ea€ a ao G o C a a. O 0€ C €COGCC C WATERMARK PATENT TRADE MARK ATTORNEYS "THE ATRIUM", 2ND FLOOR 290 BURWOOD ROAD HAWTHORN VIC. 3122
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FI871512 | 1987-04-07 | ||
FI871512A FI75865C (en) | 1987-04-07 | 1987-04-07 | TESTANORDNING OCH FOERFARANDE FOER BESTAEMNING AV ANTIBIOTIKA I MJOELK SAMT I DESSA ANVAENDBAR NY STREPTOCOCCUS THERMOPHILUS-STAM. |
Publications (2)
Publication Number | Publication Date |
---|---|
AU1415888A AU1415888A (en) | 1988-10-06 |
AU609794B2 true AU609794B2 (en) | 1991-05-09 |
Family
ID=8524275
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU14158/88A Ceased AU609794B2 (en) | 1987-04-07 | 1988-04-05 | A test set and a process for the determination of antibiotics in milk and a novel streptococcus thermophilus strain to be used therein |
Country Status (13)
Country | Link |
---|---|
US (1) | US4929546A (en) |
EP (1) | EP0285792B1 (en) |
JP (1) | JPH072119B2 (en) |
AT (1) | ATE76437T1 (en) |
AU (1) | AU609794B2 (en) |
CA (1) | CA1316442C (en) |
DD (1) | DD268481A5 (en) |
DE (1) | DE3871216D1 (en) |
DK (1) | DK173966B1 (en) |
FI (1) | FI75865C (en) |
IE (1) | IE60699B1 (en) |
NO (1) | NO174898C (en) |
NZ (1) | NZ223750A (en) |
Families Citing this family (25)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5658790A (en) * | 1986-09-04 | 1997-08-19 | Bio 101, Inc. | Cell culture media formulated in unit dose |
IL91596A0 (en) * | 1989-09-11 | 1990-04-29 | Orgenics Ltd | Microbiological assay kit and method for detecting antibacterial compounds |
DK0611001T3 (en) * | 1993-02-11 | 2002-09-09 | Dsm Nv | Device for detecting residues of antibacterial compounds in liquids |
FR2725212B1 (en) * | 1994-09-30 | 1996-12-20 | Gervais Danone Co | STREPTOCOCCUS THERMOPHILUS STRAIN, FERMENTATION PROCESS USING THIS STRAIN AND PRODUCT OBTAINED |
EP0755456B1 (en) * | 1995-02-01 | 2000-11-08 | Dsm N.V. | A rapid microbiological test for the detection of antibacterial compounds |
FR2732693B1 (en) * | 1995-04-06 | 1997-05-09 | Bio Veto Tests Bvt | CONTAMINANT REVELATION INDICATOR AND METHOD OF APPLICATION TO THE PRODUCTION OF AN ANTIBIOGRAM DIRECTLY CARRIED OUT ON A SAMPLING |
US5827675A (en) * | 1995-07-12 | 1998-10-27 | Charm Sciences, Inc. | Test apparatus, system and method for the detection of test samples |
WO1997003209A1 (en) * | 1995-07-12 | 1997-01-30 | Charm Sciences, Inc. | Test apparatus, system and method for the detection of test samples |
US5792622A (en) * | 1995-11-16 | 1998-08-11 | New Mexico State University Technology Transfer Corporation | Assay for chemicals |
WO2001025471A2 (en) * | 1999-10-04 | 2001-04-12 | Dsm N.V. | Method for the detection of antimicrobial residues |
NZ532039A (en) | 2001-10-15 | 2004-12-24 | Dsm Ip Assets B | Apparatus and method for detecting undesired residues in a sample |
WO2005005656A1 (en) * | 2003-07-02 | 2005-01-20 | Dsm Ip Assets B.V. | Improved method for the determination of the presence of an antibiotic in a fluid |
EP1664330B1 (en) | 2003-09-11 | 2008-11-19 | DSM IP Assets B.V. | Blood and urine test |
US7897365B2 (en) * | 2003-11-18 | 2011-03-01 | Charm Sciences, Inc. | Method for adjusting antibiotic sensitivity of a test culture |
US7824882B2 (en) | 2004-06-02 | 2010-11-02 | Dsm Ip Assets B.V. | Oligosaccharides in a test system for the determination of the presence of an antibiotic in a fluid |
EP1984518A1 (en) | 2006-02-08 | 2008-10-29 | DSMIP Assets B.V. | Combination of reader and incubator |
US8476064B2 (en) * | 2006-05-09 | 2013-07-02 | Charm Sciences, Inc. | Inhibition assay method and device for detection of antibiotics |
WO2011091805A1 (en) | 2010-01-29 | 2011-08-04 | Tartu Ülikool (University Of Tartu) | On-line system, method of its calibration and simultaneous detection of antibiotic residues and their concentration in milk |
WO2012156528A1 (en) | 2011-05-19 | 2012-11-22 | Dsm Ip Assets B.V. | Method for the determination of the presence of an antibiotic in a fluid |
BR112014009194A8 (en) | 2011-10-18 | 2017-06-20 | Dsm Ip Assets Bv | method for determining the presence of an antibiotic in a fluid |
EP2799881A1 (en) | 2013-05-02 | 2014-11-05 | DSM IP Assets B.V. | Method for the determination of the presence of an antibiotic in a fluid |
US9732370B2 (en) | 2013-05-02 | 2017-08-15 | Dsm Ip Assets B.V. | Method for the determination of the presence of an antibiotic in a fluid |
SI3368681T1 (en) | 2015-11-20 | 2019-11-29 | Centrient Pharmaceuticals Netherlands B V | Assay for determining antibiotics in waste |
CN106319023A (en) * | 2016-08-19 | 2017-01-11 | 浙江工商大学 | Method for quickly detecting residual antibiotic in cow's milk or chicken tissues on basis of PGM |
CN108676841A (en) * | 2018-05-25 | 2018-10-19 | 广州南侨食品有限公司 | The method of inspection of gemma and heat resistant spores |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU1052288A (en) * | 1986-12-02 | 1988-06-30 | Prosciences, Inc. | Diagnostic test for staphylococcal mastitis |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3897307A (en) * | 1974-10-23 | 1975-07-29 | Hansens Lab Inc | Stabilized dry cultures of lactic acid-producing bacteria |
DE2930394A1 (en) * | 1978-07-26 | 1980-02-14 | Seppo Kolehmainen | Determn. of antibiotic concn. in a medium - by observing change in adenosine concn. |
US4235964A (en) * | 1978-09-28 | 1980-11-25 | Bochner Barry R | Method for testing and identifying microorganisms |
US4615978A (en) * | 1979-06-28 | 1986-10-07 | The State Of Oregon, By And Through The Oregon State Board Of Higher Education On Behalf Of Oregon State University | Bacterial growth medium and method of use |
-
1987
- 1987-04-07 FI FI871512A patent/FI75865C/en not_active IP Right Cessation
-
1988
- 1988-02-25 IE IE52088A patent/IE60699B1/en not_active IP Right Cessation
- 1988-02-26 AT AT88102867T patent/ATE76437T1/en not_active IP Right Cessation
- 1988-02-26 EP EP88102867A patent/EP0285792B1/en not_active Expired - Lifetime
- 1988-02-26 DE DE8888102867T patent/DE3871216D1/en not_active Expired - Lifetime
- 1988-02-29 NO NO880885A patent/NO174898C/en not_active IP Right Cessation
- 1988-03-04 DK DK198801174A patent/DK173966B1/en not_active IP Right Cessation
- 1988-03-04 NZ NZ223750A patent/NZ223750A/en unknown
- 1988-03-15 CA CA000561516A patent/CA1316442C/en not_active Expired - Fee Related
- 1988-04-05 AU AU14158/88A patent/AU609794B2/en not_active Ceased
- 1988-04-06 US US07/178,257 patent/US4929546A/en not_active Expired - Lifetime
- 1988-04-06 DD DD88314467A patent/DD268481A5/en not_active IP Right Cessation
- 1988-04-07 JP JP63086222A patent/JPH072119B2/en not_active Expired - Lifetime
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU1052288A (en) * | 1986-12-02 | 1988-06-30 | Prosciences, Inc. | Diagnostic test for staphylococcal mastitis |
Also Published As
Publication number | Publication date |
---|---|
FI75865B (en) | 1988-04-29 |
NZ223750A (en) | 1990-03-27 |
AU1415888A (en) | 1988-10-06 |
JPS63269999A (en) | 1988-11-08 |
FI75865C (en) | 1988-08-08 |
NO174898B (en) | 1994-04-18 |
NO880885L (en) | 1988-10-10 |
NO880885D0 (en) | 1988-02-29 |
ATE76437T1 (en) | 1992-06-15 |
NO174898C (en) | 1997-11-20 |
IE60699B1 (en) | 1994-08-10 |
DK117488A (en) | 1988-10-08 |
DK117488D0 (en) | 1988-03-04 |
JPH072119B2 (en) | 1995-01-18 |
FI871512A0 (en) | 1987-04-07 |
EP0285792B1 (en) | 1992-05-20 |
DK173966B1 (en) | 2002-03-18 |
DD268481A5 (en) | 1989-05-31 |
DE3871216D1 (en) | 1992-06-25 |
CA1316442C (en) | 1993-04-20 |
EP0285792A1 (en) | 1988-10-12 |
IE880520L (en) | 1988-10-07 |
US4929546A (en) | 1990-05-29 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU609794B2 (en) | A test set and a process for the determination of antibiotics in milk and a novel streptococcus thermophilus strain to be used therein | |
Domig et al. | Methods used for the isolation, enumeration, characterisation and identification of Enterococcus spp.: 1. Media for isolation and enumeration | |
Merlino et al. | Evaluation of CHROMagar Orientation for differentiation and presumptive identification of gram-negative bacilli and Enterococcus species | |
US5786167A (en) | Method and culture medium for identification of salmonellae | |
FI67725C (en) | FOERFARANDE FOER FRAMSTAELLNING AV ENHETER AVSEDDA FOER BESTAEMNING AV ANTIBIOTIKA- OCH SULFARESTER I BIOLOGISKA VAETSKOR OCH FRAMSTAELLDA ENHETER | |
CA2027536C (en) | Method for determination of e.coli in water | |
Neal et al. | The use of 2, 3, 5-triphenyltetrazolium chloride as a test for antibiotic substances in milk | |
CN105713859B (en) | Method for detecting multiple antibiotic residues in bifidobacterium breve and milk and application | |
KR101747347B1 (en) | Method for identifying bacteria from the bacillus cereus group | |
EP1403378B1 (en) | Medium for detecting target microbes in a sample | |
WO1999032656A1 (en) | Colorimetric assessment of the sensitivity of helicobacter pylori to antimicrobial substances | |
Hayward et al. | Development of specific tests for rapid detection of Escherichia coli and all species of Proteus in urine | |
Dalet et al. | Evaluation of a new agar in Uricult-Trio for rapid detection of Escherichia coli in urine | |
US7470520B1 (en) | Method for enterobacter identification | |
Hatcher et al. | Radiometric analysis of frozen concentrated orange juice for total viable microorganisms | |
CN109971669A (en) | The detection method and application of bifidobacterium pseudocatenulatum and Residue of Antibiotics in Milk | |
RU2203317C2 (en) | Method of detection of bacillus anthracis in milk | |
US4229530A (en) | Methods and media for rapid detection of pathogenic neisseria | |
Salter et al. | Evaluation of Peel Plate™ EC for Determination of E. coli and Coliform or Total Coliform in Dairy Products | |
US4952497A (en) | Simple and rapid method for detection of virulent Yersinia enterocolitica | |
US20040241786A1 (en) | Single tube screen | |
Westhoff et al. | Detection of penicillin in milk by bioluminescence | |
ES2755385T3 (en) | Liquid nutrient medium for the cultivation of harmful clostridia in dairies and detection procedures | |
RU2154105C1 (en) | Method of quantitative estimation of bifidobacteria content in mixed cultures of microorganisms | |
JPH0799995A (en) | Determination of bifidobacterium bifidus count |